Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Seattle Genetics to Present at the J.P. Morgan Healthcare Conference

Business Wire January 6, 2015

Conkwest, Sorrento And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong

PR Newswire January 6, 2015

GLOBAL Design Manuscript Published in Journal of Cardiovascular Computed Tomography

PR Newswire January 6, 2015

LabCorp is Scheduled to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Business Wire January 6, 2015

"Walking Dead" Cast and Mike Trout Among "Most Dangerous Autographs," Experts Warn

PR Newswire January 6, 2015

Signal Genetics Appoints Sudipto Sur Chief Information Officer

GlobeNewswire January 6, 2015

Immunomedics Appoints Dr. Francois Wilhelm Chief Medical Officer

GlobeNewswire January 6, 2015

Signal Genetics Appoints Sudipto Sur Chief Information Officer

GlobeNewswire January 6, 2015

Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals' Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases

Business Wire January 6, 2015

"Ornish Diet" Named "Best Heart-Healthy Diet" by U.S. News & World Report for Fifth Year in a Row

Business Wire January 6, 2015

Intrexon to Present at the 2015 J.P. Morgan Healthcare Conference

PR Newswire January 6, 2015

Libre Wireless Technologies Announces Breakthrough WiFi Audio Streaming Modules Featuring Lowest Cost, Size and Power

Business Wire January 6, 2015

DARA BioSciences Granted Waiver of Product and Establishment Fees by the FDA

Marketwired January 6, 2015

SolaranRx to Present Melanoma-Fighting Technology at San Francisco's Biotech Showcase

Business Wire January 6, 2015

BioLineRx Completes Dose Escalation Stage of Phase 1 Trial for Novel Stem Cell Mobilization Treatment

Business Wire January 6, 2015

Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV

PR Newswire January 6, 2015

Mirati Therapeutics Doses First Patient in Investigator-Sponsored Phase 2 Study of Mocetinostat in Non-Hodgkin's Lymphoma

PR Newswire January 6, 2015

Celsion Corporation Submits DNA-based Immunotherapy Clinical Protocol to the FDA as Part of a First Line Treatment for Ovarian Cancer

PR Newswire January 6, 2015

Atmel Unleashes Highest-Performing ARM Cortex-M7 based MCUs with Superior Memory Architecture and Connectivity for Automotive, IoT and Industrial Markets

PR Newswire January 6, 2015

American Society for Cell Biology Chooses TEMIS for Science Navigator Application

PR Newswire January 6, 2015